177 related articles for article (PubMed ID: 20824566)
1. Harmful alcohol consumption and patterns of substance use in HIV-infected patients receiving antiretrovirals (ANRS-EN12-VESPA Study): relevance for clinical management and intervention.
Michel L; Carrieri MP; Fugon L; Roux P; Aubin HJ; Lert F; Obadia Y; Spire B;
AIDS Care; 2010 Sep; 22(9):1136-45. PubMed ID: 20824566
[TBL] [Abstract][Full Text] [Related]
2. [Anhedonia and depressive symptomatology among HIV-infected patients with highly active antiretroviral therapies (ANRS-EN12-VESPA)].
Préau M; Bonnet A; Bouhnik AD; Fernandez L; Obadia Y; Spire B;
Encephale; 2008 Sep; 34(4):385-93. PubMed ID: 18922241
[TBL] [Abstract][Full Text] [Related]
3. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
[TBL] [Abstract][Full Text] [Related]
4. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
[TBL] [Abstract][Full Text] [Related]
5. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
6. Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003).
Peretti-Watel P; Spire B; Pierret J; Lert F; Obadia Y;
AIDS Care; 2006 Apr; 18(3):254-61. PubMed ID: 16546787
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the prevalence of distal symmetrical polyneuropathy and its risk factors among HAART-treated and untreated HIV infected individuals.
Shurie JS; Deribew A
Ethiop Med J; 2010 Apr; 48(2):85-93. PubMed ID: 20608012
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous response to HAART across a diverse population of people living with HIV: results from the ANRS-EN12-VESPA Study.
Dray-Spira R; Spire B; Heard I; Lert F;
AIDS; 2007 Jan; 21 Suppl 1():S5-12. PubMed ID: 17159588
[TBL] [Abstract][Full Text] [Related]
9. Behavior surveillance: prevalence and factors associated with high-risk sexual behavior among HIV-infected men in Brazil in the post-HAART era.
Guimarães MD; Grinsztejn B; Chin-Hong PV; Campos LN; Gomes VR; Melo VH; Pilotto JH; Carmo RA; Palefsky JM
AIDS Behav; 2008 Sep; 12(5):741-7. PubMed ID: 18491224
[TBL] [Abstract][Full Text] [Related]
10. Unprotected sex in regular partnerships among homosexual men living with HIV: a comparison between sero-nonconcordant and seroconcordant couples (ANRS-EN12-VESPA Study).
Bouhnik AD; Préau M; Schiltz MA; Lert F; Obadia Y; Spire B;
AIDS; 2007 Jan; 21 Suppl 1():S43-8. PubMed ID: 17159586
[TBL] [Abstract][Full Text] [Related]
11. Mental health and sexual risk behaviours in a South African township: a community-based cross-sectional study.
Smit J; Myer L; Middelkoop K; Seedat S; Wood R; Bekker LG; Stein DJ
Public Health; 2006 Jun; 120(6):534-42. PubMed ID: 16684549
[TBL] [Abstract][Full Text] [Related]
12. Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour.
Smit C; Lindenburg K; Geskus RB; Brinkman K; Coutinho RA; Prins M
Addiction; 2006 Mar; 101(3):433-40. PubMed ID: 16499516
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in French people living with HIV in 2003: results from the national ANRS-EN12-VESPA Study.
Préau M; Marcellin F; Carrieri MP; Lert F; Obadia Y; Spire B;
AIDS; 2007 Jan; 21 Suppl 1():S19-27. PubMed ID: 17159583
[TBL] [Abstract][Full Text] [Related]
14. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
[TBL] [Abstract][Full Text] [Related]
15. Determinants of benzodiazepine use in a representative population of HIV-infected individuals: the role of HIV status disclosure (ANRS-EN12-VESPA study).
Roux P; Fugon L; Michel L; Lert F; Obadia Y; Spire B; Carrieri MP
AIDS Care; 2011 Sep; 23(9):1163-70. PubMed ID: 21562996
[TBL] [Abstract][Full Text] [Related]
16. Continued high risk behaviors in HIV infected drug abusers.
Miguez-Burbano MJ; Pineda-Medina L; Lecusay R; Page JB; Castillo G; Burbano X; Rodriguez A; Rodriguez N; Shor-Posner G
J Addict Dis; 2002; 21(4):67-80. PubMed ID: 12296503
[TBL] [Abstract][Full Text] [Related]
17. Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study.
Conen A; Fehr J; Glass TR; Furrer H; Weber R; Vernazza P; Hirschel B; Cavassini M; Bernasconi E; Bucher HC; Battegay M;
Antivir Ther; 2009; 14(3):349-57. PubMed ID: 19474469
[TBL] [Abstract][Full Text] [Related]
18. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
[TBL] [Abstract][Full Text] [Related]
19. Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART).
Michel L; Giorgi R; Villes V; Poizot-Martin I; Dellamonica P; Spire B; Protopopescu C; Carrieri MP
Drug Alcohol Depend; 2009 Jan; 99(1-3):96-104. PubMed ID: 18774237
[TBL] [Abstract][Full Text] [Related]
20. Health risk behaviors among HIV-infected youth in Bangkok, Thailand.
Rongkavilit C; Naar-King S; Chuenyam T; Wang B; Wright K; Phanuphak P
J Adolesc Health; 2007 Apr; 40(4):358.e1-8. PubMed ID: 17367731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
